As part of CLL Global Research Foundation’s virtual town hall, Dr. Alessandra Ferrajoli responded to audience questions – sharing insight into how low platelets and immunoglobulin levels are managed in patients with CLL.
Expert Panel:

Dr. Alessandra Ferrajoli, The University of Texas MD Anderson Cancer Center
Transcript:
Jeff Folloder: Dr. Ferrajoli, I’m going to give this one to you. What are the best ways to treat low platelets and low IgG from relapsed CLL?
This is near and dear to my heart because it describes me.
Dr. Alessandra Ferrajoli: So, this is a very challenging question. First of all, we need to determine why the platelets are low. If the platelets are low because there is involvement of the bone marrow by the CLL, then my strategy will be, and the strategy of many will be to treat the disease so that you can reduce the amount of CLL in the bone marrow, and the platelets are likely to improve. However, CLL tends to play tricks on us. Sometimes the low platelets may be due to destruction of those platelets by our immune system. Usually those platelets are destroyed in the split. In this case, we need to take a little bit of a different approach.
We usually tend to use more immunosuppressive therapy or therapies that are directed toward what we call ITP, that is this immune thrombocytopenia. Often, once we have controlled the thrombocytopenia, we tend to end up in the same place as I described before. That is if we treat the underlying CLL, it’s less likely the immune thrombocytopenia will reoccur. So, we do, again, the best approach according to what is the cause of the thrombocytopenia. And we can determine that by doing some studies, particularly it’s needed to do a bone marrow aspiration to determine whether the bone marrow is producing extra platelets and those are being destroyed or the bone marrow cannot function because there is CLL there.
As far as the second part of the question that is the lowering immunoglobulins, we have noticed that with the more recent therapies, therapies that are very effective, especially when they are given in a timely fashion, once the disease is in remission, with time, the immunoglobulin level will improve. There are, however, occasional patients that even if the CLL is in remission, it’s very well-controlled, they’ll still have low immunoglobulins. There is not an effective drug to stimulate those cells to make the immunoglobulin. But if there is an increased risk of infection, we can do infusion of immunoglobin and use them as a supplement to the care of the patient.